Heather P McDowell

Author PubWeight™ 18.03‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Surviving childhood cancer. Hosp Med 2002 2.01
2 MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness. FASEB J 2009 1.51
3 RAS signaling dysregulation in human embryonal Rhabdomyosarcoma. Genes Chromosomes Cancer 2009 1.36
4 Down-regulation of insulin-like growth factor I receptor activity by NVP-AEW541 has an antitumor effect on neuroblastoma cells in vitro and in vivo. Clin Cancer Res 2006 1.04
5 Impact of a single nucleotide polymorphism in the MDM2 gene on neuroblastoma development and aggressiveness: results of a pilot study on 239 patients. Clin Cancer Res 2008 1.03
6 c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571. Int J Cancer 2003 0.94
7 Sacrococcygeal teratoma--a 25-year experience in a UK regional center. J Pediatr Surg 2006 0.92
8 Clinical significance of CXC chemokine receptor-4 and c-Met in childhood rhabdomyosarcoma. Clin Cancer Res 2008 0.92
9 Surgical interventions for the treatment of radiation-induced alopecia in pediatric practice. Pediatr Blood Cancer 2007 0.90
10 Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family members. BMC Cancer 2014 0.89
11 MYCN sensitizes human neuroblastoma to apoptosis by HIPK2 activation through a DNA damage response. Mol Cancer Res 2010 0.88
12 Up-regulation of EphB and ephrin-B expression in rhabdomyosarcoma. Anticancer Res 2008 0.88
13 Characterization of Wnt/β-catenin signaling in rhabdomyosarcoma. Lab Invest 2013 0.87
14 Neuroblastoma: a 20-year experience in a UK regional centre. Pediatr Blood Cancer 2011 0.87
15 The p53 codon 72 Pro/Pro genotype identifies poor-prognosis neuroblastoma patients: correlation with reduced apoptosis and enhanced senescence by the p53-72P isoform. Neoplasia 2012 0.85
16 Activating PTPN11 mutations play a minor role in pediatric and adult solid tumors. Cancer Genet Cytogenet 2006 0.84
17 Vascular endothelial growth factor serum levels in children with newly diagnosed rhabdomyosarcoma. Pediatr Blood Cancer 2012 0.77
18 Clinical and molecular evidence for c-kit receptor as a therapeutic target in neuroblastic tumors. Clin Cancer Res 2005 0.76
19 Wilms' tumor--lessons and outcomes--a 25-year single center UK experience. Pediatr Hematol Oncol 2014 0.75